> Download programme as PDF (37 kb)
Thursday, 7 September 2006
| 08:30 - 09:00 | Registration and coffee |
| 09:00 - 10:45 | Opening session |
| Welcoming remarks Dr Carlo Conti Governor of the State Basel-City, Head of the Health Department of Basel-City |
|
| Chair and opening remarks Prof Mark Pieth Chairman, Basel Institute on Governance |
|
| "Public health, innovation and intellectual property rights" Ruth Dreifuss Former President of the Swiss Confederation, Chair of WHO Commission on Intellectual Property Rights, Innovation and Public Health |
|
| "Right to health - duty for whom" Prof Klaus M. Leisinger President and CEO, Novartis Foundation for Sustainable Development |
|
| "Main challenges in today's world health situation" Dr Malebona Matsoso Director, Department of Technical Cooperation for Essential Drugs and Traditional Medicines, World Health Organisation |
|
| "Availability and affordability - today's shortcomings" Dr Karim Laouabdia-Sellami Director, Campaign for Access to Essential Medicines, Médecins Sans Frontières |
|
| 10:45 - 11:15 | Coffee break |
| 11:15 - 13:00 | New dimensions |
| Prof Anton K. Schnyder (Chair) Member of the Board, Basel Institute on Governance |
|
| "Improving access to medication: ways forward from the perspective of the industry" Christopher Murray Director, Pharma International, Roche |
|
| "Shareholder vs. stakeholder approach - a financial contradiction?" Dr Luciano Jannelli Executive Director, Julius Baer |
|
| "Research and development - could we do better?" Dr Sacha Sidjanski Head of Funder Relations, Esperanza Medicines Foundation |
|
| "Access to specialised medical treatment in developing countries" Prof Thierry Carrel Director, Clinic for Cardiovascular Surgery, University Hospital of Berne |
|
| 13:00 - 14:00 | Buffet Lunch |
| 14:00 - 15:30 | Workshop 1: Industrialised countries vs. developing regions - two markets, two rules? |
| Dr Harvey Bale Jr. (Chair) Director General, International Federation of Pharmaceutical Manufacturers & Associations |
|
| Dr Konji Sebati Ambassador of South Africa to Switzerland |
|
| Dr Nicolaus Lorenz President, Medicus Mundi Network Health for All |
|
| Dr Yves Champey Chair of the Board of Directors, Drugs for Neglected Diseases Initiative |
|
| Dr Petra Dörr Head International Affairs, Swissmedic, Swiss Agency for Therapeutic Products |
|
| Workshop 2: Practical barriers to access to medication | |
| Prof Marcel Tanner (Chair) Director, Swiss Tropical Institute |
|
| Dr Guitelle Baghdadi Department of Medicines Policy and Standards, World Health Organisation |
|
| Anne Lugon-Moulin Deputy Head of Governance Division, Swiss Agency for Development and Cooperation |
|
| Silvio Gabriel Executive Vice President Malaria Initiatives, Novartis Pharma AG |
|
| Fernando Pascual Campaign for Access to Essential Medicies, Médecins sans Frontières |
|
| Workshop 3: How to finance research and equal access to medication - a Swiss perspective |
|
| Prof Lukas Handschin (Chair) Member of the Board, Basel Institute on Governance |
|
| Matthias Enderle Head, Unit on Medicine Law, Department for Biomedical Sciences, Swiss Federal Office of Public Health |
|
| Peter Fischer CEO, Visana |
|
| Vincenza Trivigno Vice President, Economic Affairs, IPR, Interpharma |
|
| Dr Anne Witschi Head of the public health unit, Health Department of Basel-Stadt, Switzerland |
|
| 15:30 - 16:00 | Workshop reports to the plenary |
| Chairpersons of workshops | |
| 16:00 - 16:30 | Coffee break |
| 16:30 - 17:10 | Scenarios for the future |
| Prof Anne Peters (Chair) Member of the Board, Basel Institute on Governance |
|
| "The scenario for the future, an academic perspective" Prof Mark Pieth Chairman, Basel Institute on Governance |
|
| "One pragmatic scenario: Development of new clinical interventions to fight poverty related diseases" Dr Pascoal Mocumbi Former Prime Minister of Mozambique, High Representative, European and Developing Countries Clinical Trials Partnership |
|
| 17:10 - 18:15 | Closing panel discussion |
| Prof Klaus M. Leisinger President and CEO, Novartis Foundation for Sustainable Development |
|
| Prof Marcel Tanner Director, Swiss Tropical Institute |
|
| Dr Konji Sebati Ambassador of South Africa to Switzerland |
|
| Dr Karim Laouabdia-Sellami Director, Campaign for Access to Essential Medicines, Médecins sans Frontières |
|
| Dr Malebona Matsoso Director, Department of Technical Cooperation for Essential Drugs and Traditional Medicines, World Health Organisation |
|
| 18:15 | Closing remarks Prof Mark Pieth Chairman, Basel Institute on Governance |
| 18:30 | Cocktails hosted by Interpharma, Conference Center |
| 19:30 | Dinner hosted by Interpharma, Restaurant Safran Zunft |